GlassScriptPhysician profile
Jason C Schroeder
NPI 1821678814
$2,724.99
in general payments reported to CMS, 2019-2025
9 companies · $2,671 in 2025
The $2,671 reported for 2025 was more than what 95% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $53.77 · 2025: $2,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453 · Travel and Lodging: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.35 |
| Travel and Lodging | $1,271.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,259.86 | 2025 | Wavewriter Alpha Prime 16, Clinical Trial Product, Intracept Rf Probe |
| Globus Medical, INC. | $501.75 | 2025 | Senza |
| Biotronik Nro, INC. | $345.33 | 2025 | Prospera |
| Si-Bone, INC. | $163.33 | 2025 | |
| Wenzel Spine, INC. | $154.46 | 2025 | Varilift |
| Avanos Medical | $123.97 | 2025 | Coolief Cooled Radiofrequency |
| Piramal Critical Care | $108.63 | 2025 | |
| Averitas Pharma INC. | $53.77 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $13.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.